Form D · Other Health Care
Braxia Scientific Corp.
Vancouver, A1 · CIK 0001815476
Offering snapshot reported Mar 21, 2024 · SEC filing
- Reported sold
- $249K Offering amount: $730K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 27, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2024 | Amendment | $249,024 | $0vs Mar 24, 2023 | 3 | SEC filing |
| Aug 23, 2023 | Amendment | $2,283,537 | $0vs Aug 22, 2022 | 35 | SEC filing |
| Mar 24, 2023 | Initial | $249,024 | No comparison | 3 | SEC filing |
| Aug 22, 2022 | Initial | $2,283,537 | No comparison | 35 | SEC filing |
| Feb 14, 2022 | Initial | $2,366,078 | No comparison | 4 | SEC filing |
| Jun 23, 2020 | Initial | $950,552 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-476827
The additional $481,036 may be received upon the exercise of share purchase warrants sold inside or outside the US. The dollar amounts are based on the Bank of Canada average rate of exchange reported on 2/27/2023, which was CAD$1.3573=USD$1.00
Each unit consists of one common share and one common share purchase warrant. Each warrant is exercisable for one common share at an exercise price of CAD$0.07 per share for 36 months.
Source: Form D, filed Mar 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gareth Birdsall | Director |
| Stephen Brohman | Executive |
| Stephen Brooks | Executive |
| Olga Cwiek | Director |
| Matthew Fish | Director, Executive |
| David Greenberg | Director |
| Jerry Habuda | Director |
| Daniel Herrera | Executive |
| Kevin Kratiuk | Executive |
| Pat Mc Cutcheon | Director |
| Roger Mc Intyre | Director, Executive |
| Peter Rizakos | Executive |
| Joshua Rosenblat | Executive |
| Bill Wilkerson | Director |
| Jason Wolkove | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:Vancouver, A1, V6E2K3